Amgen Inc/ US0311621009 /
1/24/2025 10:00:00 PM | Chg. -2.4600 | Volume | Bid1:26:09 AM | Ask1:26:09 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
275.4200USD | -0.89% | 2.01 mill. Turnover: 331.49 mill. |
274.2000Bid Size: 200 | 277.2000Ask Size: 100 | 148.05 bill.USD | 3.14% | 21.93 |
GlobeNewswire
8/29/2024
Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...
GlobeNewswire
8/28/2024
Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...
GlobeNewswire
8/15/2024
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire
8/12/2024
TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
8/8/2024
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
8/8/2024
Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
GlobeNewswire
8/5/2024
Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
GlobeNewswire
8/1/2024
CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024